Usefulness of β-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes

American Journal of Cardiology

Volumn 110, Issue 9, 2012, Pages 1240-1248

  Manzano Fernández, Sergio ^a   López Cuenca, Ángel ^a   Januzzi, James L ^b   Parra Pallares, Soledad ^a   Mateo Martínez, Alicia ^a   Sánchez Martínez, Marianela ^a   Pérez Berbel, Patricio ^c   Orenes Piñero, Esteban ^a   Romero Aniorte, Ana I ^a   Avilés Plaza, Francisco ^a   Valdés Chavarri, Mariano ^a   Marín, Francisco ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TRACE PROTEIN; CREATININE; CYSTATIN C; LIPOCALIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

ACUTE CORONARY SYNDROME; AGE FACTORS; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BIOLOGICAL MARKERS; CAUSE OF DEATH; COHORT STUDIES; CONFIDENCE INTERVALS; CREATININE; CYSTATIN C; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; KAPLAN-MEIER ESTIMATE; LIPOCALINS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 84867399641     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.06.027     Document Type: Article

References (24)

1. F. Priem, H. Althaus, M. Birnbaum, P. Sinha, H.S. Conradt, K. Jung Beta-trace protein in serum: a new marker of glomerular filtration rate in the creatinine-blind range Clin Chem 45 1999 567 568
2. F. Priem, H. Althaus, K. Jung, P. Sinha Beta-trace protein is not better than cystatin C as an indicator of reduced glomerular filtration rate Clin Chem 47 2001 2181
3. G. Filler, F. Priem, N. Lepage, P. Sinha, I. Vollmer, H. Clark, E. Keely, M. Matzinger, A. Akbari, H. Althaus, K. Jung Beta-trace protein, cystatin C, beta(2)-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children Clin Chem 48 2002 729 736
4. S. Manzano-Fernández, J.L. Januzzi Jr, M. Boronat-Garcia, J.C. Bonaque-González, Q.A. Truong, F.J. Pastor-Pérez, C. Muñoz-Esparza, P. Pastor, M.D. Albaladejo-Otón, T. Casas, M. Valdés, D.A. Pascual-Figal Beta-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure J Am Coll Cardiol 57 2011 849 858
5. M.E. Bertrand, M.L. Simoons, K.A. Fox, L.C. Wallentin, C.W. Hamm, E. McFadden, P.J. De Feyter, G. Specchia, W. Ruzyllo Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Eur Heart J 23 2002 1809 1840
6. J.P. Bassand, C.W. Hamm, D. Ardissino, E. Boersma, A. Budaj, F. Fernández-Avilés, K.A. Fox, D. Hasdai, E.M. Ohman, L. Wallentin, W. Wijns Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1598 1660
7. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, D. Roth Modification of Diet in Renal Disease Study Group A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Ann Intern Med 130 1999 461 470
8. M.J. Pencina, R.B. D'Agostino Sr, R.B. D'Agostino Jr, R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
9. I. Goldenberg, I. Subirana, V. Boyko, J. Vila, R. Elosua, G. Permanyer-Miralda, I. Ferreira-González, M. Benderly, V. Guetta, S. Behar, J. Marrugat Relation between renal function and outcomes in patients with non-ST-segment elevation acute coronary syndrome: real-world data from the European Public Health Outcome Research and Indicators Collection Project Arch Intern Med 170 2010 888 895
10. D. Hasdai, S. Behar, L. Wallentin, N. Danchin, A.K. Gitt, E. Boersma, P.M. Fioretti, M.L. Simoons, A. Battler A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS) Eur Heart J 23 2002 1190 1201
11. J.C. Verhave, R.T. Gansevoort, H.L. Hillege, D. De Zeeuw, G.C. Curhan, P.E. De Jong Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function J Am Soc Nephrol 15 2004 1316 1332
12. M.G. Shlipak, M.J. Sarnak, R. Katz, L.F. Fried, S.L. Seliger, A.B. Newman, D.S. Siscovick, C. Stehman-Breen Cystatin C and the risk of death and cardiovascular events among elderly persons N Engl J Med 352 2005 2049 2060
13. T. Keller, C.M. Messow, E. Lubos, V. Nicaud, P.S. Wild, H.J. Rupprecht, C. Bickel, S. Tzikas, D. Peetz, K.J. Lackner, L. Tiret, T.F. Münzel, S. Blankenberg, R.B. Schnabel Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study Eur Heart J 30 2009 314 320
14. P. Solichova, L. Novackova, R. Ochmanova, D. Stejskal Assessment of serum beta-trace protein (BTP) measurement in the prediction of glomerular filtration rate Comparison with serum cystatin C Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150 2006 83 84
15. O. Simonsen, A. Grubb, H. Thysell The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate Scand J Clin Lab Invest 45 1985 97 101
16. R. Schuligoi, M. Grill, A. Heinemann, B.A. Peskar, R. Amann Sequential induction of prostaglandin E and D synthases in inflammation Biochem Biophys Res Commun 335 2005 684 689
17. P. Eriksson, H. Deguchi, A. Samnegard, P. Lundman, S. Boquist, P. Tornvall, C.G. Ericsson, L. Bergstrand, L.O. Hansson, S. Ye, A. Hamsten Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease Arterioscler Thromb Vasc Biol 24 2004 551 557
18. G.P. Shi, G.K. Sukhova, A. Grubb, A. Ducharme, L.H. Rhode, R.T. Lee, P.M. Ridker, P. Libby, H.A. Chapman Cystatin C deficiency in human atherosclerosis and aortic aneurysms J Clin Invest 104 1999 1191 1197
19. T. Inoue, Y. Eguchi, T. Matsumoto, Y. Kijima, Y. Kato, Y. Ozaki, K. Waseda, H. Oda, K. Seiki, K. Node, Y. Urade Lipocalin-type prostaglandin D synthase is a powerful biomarker for severity of stable coronary artery disease Atherosclerosis 201 2008 385 391
20. T. Matsumoto, Y. Eguchi, H. Oda, T. Yamane, Y. Tarutani, T. Ozawa, H. Hayashi, I. Nakae, M. Horie, Y. Urade Lipocalin-type prostaglandin D synthase is associated with coronary vasospasm and vasomotor reactivity in response to acetylcholine Circ J 75 2011 897 904
21. C. Mena, N.R. Robles, J.M. de Prado, F.G. Gallego, A. Cidoncha Cystatin C and blood pressure: results of 24 h ambulatory blood pressure monitoring Eur J Intern Med 21 2010 185 190
22. N. Hirawa, Y. Uehara, M. Yamakado, Y. Toya, T. Gomi, T. Ikeda, Y. Eguchi, M. Takagi, H. Oda, K. Seiki, Y. Urade, S. Umemura Lipocalin-type prostaglandin d synthase in essential hypertension Hypertension 39 2002 449 454
23. H. Takano, I. Komuro Peroxisome proliferator-activated receptor gamma and cardiovascular diseases Circ J 73 2009 214 220
24. F. Cipollone, M. Fazia, A. Iezzi, G. Ciabattoni, B. Pini, C. Cuccurullo, S. Ucchino, F. Spigonardo, M. De Luca, C. Prontera, F. Chiarelli, F. Cuccurullo, A. Mezzetti Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans Arterioscler Thromb Vasc Biol 24 2004 1259 1265